-The Times of India One in every five Indian adults living in urban cities suffers not only from hypertension but also diabetes. In Maharashtra, more disturbingly, one in three persons is struck by the twin epidemic. These are some of the highlights of India's largest clinic-based survey to assess the prevalence of diabetes and hypertension. The findings of the study, called Screening India's Twin Epidemic (SITE), were announced on Monday in...
More »SEARCH RESULT
Can the Planning Commission be reinvented? by Sanjeeb Mukherjee, Indivjal Dhasmana & Vrishti Beniwal
Caught in the middle of a maelstrom of controversies, the Planning Commission has been accused of being disconnected from ground realities. Its 12th Plan hopes to fix that. A short while ago, the Congress general secretary and scion of the Nehru-Gandhi dynasty, Rahul Gandhi, remarked that members of the Planning Commission are not in touch with the ground realities in India. He could have been somewhat influenced by his father, former...
More »Medicines: For Saving Life or For Superprofits? by Bharat Dogra
Will patent rights be used only for ensuring the legitimate interests of pharmaceutical companies, or will these be used in an exaggerated and unjust way to deprive patients of their right to life? This crucial question, which has been debated time and again in the context of the significant case of Glivec, an anti-cancer drug, has now reached a critical stage. It may be pointed out here that as early as...
More »Bitter pill for Big pharma by Bhupesh Bhandari
A committee headed by Planning Commission member Arun Maira, the former head of The Boston Consulting Group in India, wants all acquisitions of Indian pharmaceutical companies by foreigners to be scanned by the Competition Commission of India or CCI. The report will now be sent to Prime Minister Manmohan Singh and Planning Commission Deputy Chairman Montek Singh Ahluwalia. Prime Minister Singh is expected to take a final view on the...
More »Affordable medicine
-The Business Standard It appears a committee headed by Planning Commission member Arun Maira examining the case for continued unrestricted foreign direct investment (FDI) in the pharmaceutical industry has opted to oppose the move to change the present regime. The only concession it is willing to make to the health and commerce ministries’ demand that approval of such investment be routed through the Foreign Investment Promotion Board is to ask for...
More »